DIN 02432226 — HARVONI 400 MG; 90 MG
HARVONI is a tablet of Ledipasvir / Sofosbuvir marketed by GILEAD SCIENCES CANADA INC. The full Ledipasvir / Sofosbuvir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02432226
- Brand name
- HARVONI
- Active ingredient
- Ledipasvir / Sofosbuvir
- Strength
- 400 MG; 90 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Direct-acting antiviral combination (NS5A inhibitor + NS5B polymerase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.